Correlation Between Cue Biopharma and Precision BioSciences

Can any of the company-specific risk be diversified away by investing in both Cue Biopharma and Precision BioSciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cue Biopharma and Precision BioSciences into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Cue Biopharma and Precision BioSciences, you can compare the effects of market volatilities on Cue Biopharma and Precision BioSciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cue Biopharma with a short position of Precision BioSciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cue Biopharma and Precision BioSciences.

Diversification Opportunities for Cue Biopharma and Precision BioSciences

0.19

Correlation Coefficient

Cue Biopharma  Precision BioSciences

Average diversification

The 3 months correlation between Cue and Precision is 0.19. Overlapping area represents the amount of risk that can be diversified away by holding Cue Biopharma and Precision BioSciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Precision BioSciences and Cue Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cue Biopharma are associated (or correlated) with Precision BioSciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Precision BioSciences has no effect on the direction of Cue Biopharma i.e., Cue Biopharma and Precision BioSciences go up and down completely randomly.

Pair Corralation between Cue Biopharma and Precision BioSciences

Considering the 90-day investment horizon Cue Biopharma is expected to generate 6.3 times less return on investment than Precision BioSciences. In addition to that, Cue Biopharma is 1.09 times more volatile than Precision BioSciences. It trades about 0.01 of its total potential returns per unit of risk. Precision BioSciences is currently generating about 0.05 per unit of volatility. If you would invest  426.00  in Precision BioSciences on December 28, 2024 and sell it today you would earn a total of  44.00  from holding Precision BioSciences or generate 10.33% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Cue Biopharma  vs.  Precision BioSciences

Cue Biopharma

Risk-Adjusted Performance

Weak

Over the last 90 days Cue Biopharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, Cue Biopharma is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.

Precision BioSciences

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Precision BioSciences are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite quite weak forward indicators, Precision BioSciences disclosed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Cue Biopharma and Precision BioSciences

The main advantage of trading using opposite Cue Biopharma and Precision BioSciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cue Biopharma position performs unexpectedly, Precision BioSciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Precision BioSciences will offset losses from the drop in Precision BioSciences' long position.

The idea behind Cue Biopharma and Precision BioSciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.